Concerning the performance of the AST/ALT ratio, it is essential to emphasize that liver enzymes are both vague and insensitive indicators of NAFLD; as a result, these tests cannot demonstrate the existence of NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.